Cargando…

Targeting mitochondria as an anticancer strategy

Detalles Bibliográficos
Autores principales:	Dong, Lanfeng, Neuzil, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815053/ https://www.ncbi.nlm.nih.gov/pubmed/31653274 http://dx.doi.org/10.1186/s40880-019-0412-6

Ejemplares similares

Role of mitochondria in regulating microRNA activity and its relevance to the central nervous system
por: Wang, Wang-Xia, et al.
Publicado: (2015)

Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy
por: Dong, Lanfeng, et al.
Publicado: (2020)

Prime time for base editing in the mitochondria
por: Morgan, Michael A., et al.
Publicado: (2022)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Mitochondria hyperactivity contributes to social behavioral impairments
por: Zhang, Yun, et al.
Publicado: (2020)

Mitochondria—A billion years of cohabitation
por: Roberts, Roland G.
Publicado: (2017)

Mechanisms of resistance to mitochondria-targeted therapy in pancreatic cancer
por: Boukalova, Stepana, et al.
Publicado: (2021)

ELANE: an emerging lane to selective anticancer therapy
por: Peng, Boqiang, et al.
Publicado: (2021)

New strategies for cancer immunotherapy: targeting regulatory T cells
por: Finotello, Francesca, et al.
Publicado: (2017)

Dark side of cyanobacteria: searching for strategies to control blooms
por: Huertas, María José, et al.
Publicado: (2021)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

Targeting H3K36 methyltransferases NSDs: a promising strategy for tumor targeted therapy
por: Peng, Xuerun, et al.
Publicado: (2021)

“Moonlighting” at the power plant: how mitochondria facilitate serial killing by CD8(+) cytotoxic T cells
por: Mougiakakos, Dimitrios, et al.
Publicado: (2021)

Immune receptor mimicking hormone receptors: a new guarding strategy
por: Liu, Xueru, et al.
Publicado: (2023)

Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
por: Almeida, Catarina R., et al.
Publicado: (2021)

Decoding γδ T cell anticancer therapies: integrating CRISPR screens with tumor organoids
por: Zhou, Jian, et al.
Publicado: (2023)

Controlling glutathione entry into mitochondria: potential roles for SLC25A39 in health and (treatment of) disease
por: von Bohlen und Halbach, Oliver
Publicado: (2022)

Targeting menin: a promising therapeutic strategy for susceptible acute leukemia subtypes
por: Di Fazio, Pietro
Publicado: (2023)

Induction of membraneless organelles as a strategy for HIV-1 post-nuclear entry steps
por: Zhou, Sheng, et al.
Publicado: (2023)

Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer Agents
por: Modica-Napolitano, Josephine S., et al.
Publicado: (2015)

Targeting copper to combat macrophage-driven inflammation: a potential advanced therapeutic strategy
por: Weiskirchen, Ralf
Publicado: (2023)

The p(l)ot thickens: cannabinoid receptors on astroglial mitochondria coordinate animal behaviors by regulating lactate availability for neurons
por: Keimpema, Erik, et al.
Publicado: (2020)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

Mitochondria break through cellular boundaries
por: Neuzil, Jiri, et al.
Publicado: (2019)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

Targeting chemokines/chemokine receptors: a promising strategy for enhancing the immunotherapy of pancreatic ductal adenocarcinoma
por: Gong, Ruining, et al.
Publicado: (2020)

Circular RNA vaccine, a novel mRNA vaccine design strategy for SARS‐CoV‐2 and variants
por: Su, Peng, et al.
Publicado: (2022)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Strategies to avoid a missed diagnosis of co-occurring concussion in post-acute patients having a spinal cord injury
por: Kushner, David S.
Publicado: (2015)

How will previous infection or current vaccination strategies protect us from future SARS‐CoV‐2 variant infections?
por: Monteiro, Olivia
Publicado: (2022)

Antigen targeting to dendritic cells: Still a place in future immunotherapy?
por: Stoitzner, Patrizia, et al.
Publicado: (2022)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

Targeting NR4As, a new strategy to fine-tune CAR-T cells against solid tumors
por: Li, Feng, et al.
Publicado: (2019)

Targeting metabolic/epigenetic pathways: a potential strategy for cancer therapy in diffuse intrinsic pontine gliomas
por: Zhao, Kun, et al.
Publicado: (2020)

Regenerative potential of targeting glycogen synthase kinase-3 signaling in neural tissues
por: Jung, Eui-Man, et al.
Publicado: (2015)

Promising inhibitors targeting M(pro): an ideal strategy for anti-SARS-CoV-2 drug discovery
por: Chen, Yi, et al.
Publicado: (2020)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein
por: Wang, Junzhi
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gijrm0hcab2dfg137bgplfj3at